Recent News from Powered by CARB-X Companies
- Forge Therapeutics announced the formation of a Scientific Advisory Board with world renowned antibiotic and drug development experts. Read More
- Tetraphase Pharmaceuticals announced top-line Phase 3 data for complicated intra-abdominal infections. Read More
- Cidara Therapeutics announced publication of results from an in vivo study of its novel antifungal candidate CD101. Read More
- In welcome funding news, VenatoRx Pharmaceuticals raised $42M to fund antibiotic R&D from Versant Ventures, Abingworth and Foresite Capital. Read More